ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

22 links0 made here, not in the record24 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02711137Open-Label Safety andTolerability Study ofINCB057643 in Subjects WithAdvanced MalignanciesIncyte CorporationPhase 1/Phase 2 · terminatedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSLymphomaThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseAs of now · Our main-condition rule (R9) · Main conditionMain conditionLeukemiaThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseMyelodysplastic SyndromesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termMultiple MyelomaThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termMyeloproliferative DisordersThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Wider: a narrower term is filedWider: a narrower term is filedPrimary MyelofibrosisThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termPancreatic NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termColorectal NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termProstatic NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termGlioblastomaThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termLymphoma, Non-HodgkinThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseLymphoma, Large B-Cell, Dif…The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termDRUGSINCB057643Intervention entry›Nov 18 · Our role rule · TestedTestedGemcitabineIntervention entry›Nov 18 · Our role rule · BackgroundBackgroundPaclitaxelIntervention entry›Nov 18 · Our role rule · BackgroundBackgroundRucaparibIntervention entry›Nov 10 · Claude Opus 5.5 · Background · partnerNov 18 · Our role rule · BackgroundBackground · partnerAbirateroneIntervention entry›Nov 18 · Our role rule · BackgroundBackgroundRuxolitinibIntervention entry›Nov 18 · Our role rule · BackgroundBackgroundAzacitidineIntervention entry›Nov 18 · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Rucaparib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Rucaparib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background · partner
Background · partner · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 10RucaparibClaude Opus 5.5Background · partnerCurrent
Nov 14LymphomaOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14LeukemiaOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Myelodysplastic SyndromesOur condition-kind ruleFinest filed termCurrent
Nov 14Multiple MyelomaOur condition-kind ruleFinest filed termCurrent
Nov 14Myeloproliferative DisordersOur condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Primary MyelofibrosisOur condition-kind ruleFinest filed termCurrent
Nov 14Pancreatic NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Colorectal NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Non-Small-Cell LungOur condition-kind ruleFinest filed termCurrent
Nov 14Prostatic NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Breast NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Ovarian NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14GlioblastomaOur condition-kind ruleFinest filed termCurrent
Nov 14Lymphoma, Non-HodgkinOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Lymphoma, Large B-Cell, DiffuseOur condition-kind ruleFinest filed termCurrent
Nov 18INCB057643Our role ruleTestedCurrent
Nov 18GemcitabineOur role ruleBackgroundCurrent
Nov 18PaclitaxelOur role ruleBackgroundCurrent
Nov 18RucaparibOur role ruleBackgroundAgrees
Nov 18AbirateroneOur role ruleBackgroundCurrent
Nov 18RuxolitinibOur role ruleBackgroundCurrent
Nov 18AzacitidineOur role ruleBackgroundCurrent
As of nowLymphomaOur main-condition rule (R9)Main conditionCurrent